These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4143918)

  • 1. Human blood platelets as cellular models for investigation of membrane active drugs: beta-adrenergic blocking agents.
    Lemmer B; Wiethold G; Hellenbrecht D; Bak IJ; Grobecker H
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 275(3):299-313. PubMed ID: 4143918
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of beta-blocking agents.
    Goldstein RE
    Circulation; 1973 Mar; 47(3):443-5. PubMed ID: 4144218
    [No Abstract]   [Full Text] [Related]  

  • 4. Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
    Hellenbrecht D; Lemmer B; Wiethold G; Grobecker H
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(2):211-26. PubMed ID: 4145013
    [No Abstract]   [Full Text] [Related]  

  • 5. [Basis for the use of beta-receptor blockaders in the practice].
    Blankart R
    Schweiz Rundsch Med Prax; 1973 Aug; 62(32):975-8. PubMed ID: 4147247
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
    Levy JV
    Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane effects of beta-adrenergic blocking agents: investigations with the fluorescence probe 1-anilino-8-naphthalene sulfonate (ANS) and antihemolytic activities.
    Wiethold G; Hellenbrecht D; Lemmer B; Palm D
    Biochem Pharmacol; 1973 Jun; 22(12):1437-49. PubMed ID: 4147326
    [No Abstract]   [Full Text] [Related]  

  • 8. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A; Kostka-Trabka E; Gryglewski R
    Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of the hemodynamic action of beta-adrenolytics in narcotized cats.
    Górka Z
    Acta Med Pol; 1973; 14(1):7-26. PubMed ID: 4144422
    [No Abstract]   [Full Text] [Related]  

  • 10. [Editorial: Importance of cardioselectivity and sympaticomimetric potential of beta-blockers (author's transl)].
    Dubach UC
    Schweiz Rundsch Med Prax; 1975 Sep; 64(39):1239-41. PubMed ID: 241073
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of beta-adrenoceptor blocking properties of sotalol, oxprenolol, propranolol and pindolol on rabbit intestinal smooth muscle.
    Salimi M
    Pharmacology; 1975; 13(5):441-7. PubMed ID: 1802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of beta-adrenoreceptor blocking agents after intracerebroventricular administration in conscious normotensive cats.
    Day MD; Roach AG
    Clin Exp Pharmacol Physiol; 1974; 1(4):333-9. PubMed ID: 4156505
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac toxicity of -lytic drugs.
    Roba J
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:120-. PubMed ID: 4403294
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of new -andrenergic blockers, C-3, Kö1366, Y-6124 and YB-2, with pindolol and propranolol in the blood perfused canine papillary muscle preparation.
    Kimura T; Endoh M; Taira N; Hashimoto K
    Experientia; 1972 Jul; 28(7):813-4. PubMed ID: 4144585
    [No Abstract]   [Full Text] [Related]  

  • 15. The brain as a possible site for the cardiovascular effects of beta-adrenoceptor blocking agents in cats.
    Day MD; Roach AG
    Clin Sci Mol Med Suppl; 1975 Jun; 2():269s-272s. PubMed ID: 28878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the effects of propranolol, practolol, oxyprenolol and L.B. 46 on myocardial contractility].
    Adamska-Dyniewska H
    Wiad Lek; 1973 Apr; 26(7):603-8. PubMed ID: 4144788
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of -adrenergic blocking agents in presence of adrenergic tone.
    Elharrar V; Nadeau RA
    Can J Physiol Pharmacol; 1972 May; 50(5):381-8. PubMed ID: 4402699
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of beta adrenoceptor blocking drugs on the integrity of rat platelets as measured by 51Cr liberation.
    Turcáni P; Nosál R
    Thromb Res; 1981 Jul 1-15; 23(1-2):187-91. PubMed ID: 6117953
    [No Abstract]   [Full Text] [Related]  

  • 19. The haemodynamic effects of ( )-propranolol, dexpropranolol, oxprenolol, practolol and sotalol in anaesthetised dogs.
    Fitzgerald JD; Wale JL; Austin M
    Eur J Pharmacol; 1972 Jan; 17(1):123-34. PubMed ID: 4401429
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardioselective beta-adrenergic blockade.
    Fitzgerald JD
    Proc R Soc Med; 1972 Sep; 65(9):761-4. PubMed ID: 4404402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.